Pharmacokinetics of intravenous fluticasone propionate in healthy subjects
about
Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulationsPharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via TurbuhalerFluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma.Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluatedRisk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective.Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease.Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone.Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal sprayEfficacy and safety of inhaled corticosteroids relative to fluticasone propionate: a systematic review of randomized controlled trials in asthma.The combination of population pharmacokinetic studies.Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.Efficacy and safety of inhaled corticosteroids. New developments.A pharmacokinetic simulation tool for inhaled corticosteroids.Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate.Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.Secondary Adrenal Insufficiency Due to the Co-Administration of Ritonavir and Inhaled Fluticasone Propionate: Case report.Detection of fluticasone propionate in horse plasma and urine following inhaled administration.Pharmacokinetic/Pharmacodynamic Evaluation of Systemic Effects of Flunisolide after Inhalation
P2860
Q28347069-282E096F-233D-4185-8183-C5AF400D39FBQ28365894-3858E728-D61B-47BB-897F-CDA833FC2479Q34181951-1454F396-1494-4543-AF6E-B31E47F4C0F9Q34620179-5A01546A-C622-4F12-9027-8DB34883D2F1Q35610011-5ADF18BA-0CBA-4B7D-8D54-4E50EE226BF1Q35841604-9DD6D86C-CD0F-4A0F-A22F-A258227F9B0FQ35995856-10349FE3-05A5-47F3-8B88-AAC57D9A68E5Q36087980-9A65148B-702D-4929-8ED3-B6B9BD9548BCQ40104404-F891CB02-CB33-4040-95F3-4DA12DA1DFE9Q40767965-8455F009-A1FB-482F-BF92-D78659C3A030Q41597242-3B0741CA-5E8F-4005-B9BE-AF9973D44E00Q41728966-F629EBCA-44B8-442F-AB23-9245E67D1048Q42507245-0495D1E7-90A3-429F-B7FA-246F83253FCCQ42678294-7E3512E6-0D32-4E1C-8483-CBB52F5FBA4EQ43164710-6EF3390F-7134-4169-A04F-C04105B959A8Q43836979-DE8F15DD-F5C1-43BF-AF8D-CA129630AD13Q45418508-1C458A49-ABFD-4008-9AB6-D29354F10F24Q46888365-6FB09D2A-9983-4C9B-899B-60632924EDEAQ58869687-B8702631-6159-4006-9C88-6277E0B77FD8
P2860
Pharmacokinetics of intravenous fluticasone propionate in healthy subjects
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Pharmacokinetics of intravenous fluticasone propionate in healthy subjects
@en
type
label
Pharmacokinetics of intravenous fluticasone propionate in healthy subjects
@en
prefLabel
Pharmacokinetics of intravenous fluticasone propionate in healthy subjects
@en
P2093
P1476
Pharmacokinetics of intravenous fluticasone propionate in healthy subjects
@en
P2093
P304
P356
10.1046/J.1365-2125.1996.36110.X
P407
P577
1996-06-01T00:00:00Z